The breakdown in the US-China trade agreement, the doubling of US steel and aluminum tariffs, and Ukraine's daring drone attack have rattled the market, sending stocks, bonds, and the dollar lower.
According to TheFly, Wells Fargo analyst Mike Mayo stated that Citi is on the cusp of transitioning from value destruction to value creation, noting that the stock should rise above its tangible book value.
The $45 million purchase was financed using the company’s available cash, which stood at $61.3 million as of the end of March, bolstered by proceeds from its at-the-market equity offering.
Amid tariff uncertainty and its possibly adverse implications for inflation and corporate earnings, the major US equity indices, after massive rallies post-April lows, are witnessing sellers come out at/near resistance.
Guardian Pharmacy Services acquires Mercury Pharmacy Services in Washington, expanding its presence in the Pacific Northwest and meeting growing demand for LTC support.
SAIC stock down after reporting Q1 2026 earnings. Sales up 2%, EPS misses estimates. CEO notes progress against growth strategy. Lower revenue and EPS outlook.
BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones totaling up to $7.6 billion.
Separately, Regeneron on Monday also announced positive interim data from its ongoing Phase 2 trial investigating novel combinations of semaglutide and Trevogrumab with or without garetosmab for the treatment of obesity.
